Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$143.18
-1.1%
$149.15
$66.03
$161.00
$8.43B0.5285,496 shs244,223 shs
BAT
Batero Gold
C$0.06
+20.0%
C$0.03
C$0.02
C$0.06
C$6.91M1.550,071 shs11,000 shs
Dios Exploration Inc. stock logo
DOS
Dios Exploration
C$0.04
C$0.04
C$0.03
C$0.14
C$4.85M2.1977,359 shs17,000 shs
MEX
Mexican Gold Mining
C$0.12
-4.0%
C$0.09
C$0.06
C$0.14
C$2.55M1.4111,198 shs777 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-1.14%+0.71%-0.89%+8.68%+82.72%
BAT
Batero Gold
0.00%+9.09%+140.00%+140.00%+71.43%
Dios Exploration Inc. stock logo
DOS
Dios Exploration
0.00%0.00%+14.29%0.00%-33.33%
MEX
Mexican Gold Mining
-4.00%-4.00%+60.00%+84.62%+14.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
1.3605 of 5 stars
3.41.00.00.01.81.70.6
BAT
Batero Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/AN/AN/AN/AN/AN/AN/AN/A
MEX
Mexican Gold Mining
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.88
Moderate Buy$173.2521.00% Upside
BAT
Batero Gold
N/AN/AN/AN/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/AN/AN/AN/A
MEX
Mexican Gold Mining
N/AN/AN/AN/A

Current Analyst Ratings

Latest ASND, DOS, MKA, BAT, and MEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$116.00 ➝ $116.00
4/18/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
4/2/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $167.00
4/1/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
3/15/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$196.00 ➝ $260.00
2/8/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$146.00 ➝ $182.00
2/8/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$207.00 ➝ $225.00
2/6/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$152.00 ➝ $173.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$288.08M28.94N/AN/A($2.73) per share-52.45
BAT
Batero Gold
N/AN/AC$0.01 per share5.83C$0.41 per shareN/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/AN/AC$0.00 per share9.38C$0.06 per shareN/A
MEX
Mexican Gold Mining
C$-405.00-6,290.37C$0.01 per share20.00C$0.02 per share6.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$521.07M-$9.25N/AN/AN/A-180.61%-16,574.15%-55.10%4/25/2024 (Estimated)
BAT
Batero Gold
N/AN/AN/AN/AN/A-1.09%-0.51%N/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/AN/AN/AN/AN/A0.10%-1.56%6/21/2024 (Estimated)
MEX
Mexican Gold Mining
N/A-C$0.02N/AN/AN/A-284.36%-134.57%N/A

Latest ASND, DOS, MKA, BAT, and MEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024N/A
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A-$1.60-$1.60N/AN/AN/A
2/7/2024Q4 2023
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$2.15-$1.66+$0.49-$1.66$97.02 million$148.62 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/AN/AN/AN/AN/A
BAT
Batero Gold
N/AN/AN/AN/AN/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/AN/AN/AN/AN/A
MEX
Mexican Gold Mining
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
3.56
2.50
BAT
Batero Gold
1.55
0.34
4.25
Dios Exploration Inc. stock logo
DOS
Dios Exploration
1.10
2.04
2.04
MEX
Mexican Gold Mining
N/A
19.60
1.92

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
BAT
Batero Gold
N/A
Dios Exploration Inc. stock logo
DOS
Dios Exploration
4.11%
MEX
Mexican Gold Mining
N/A

Insider Ownership

CompanyInsider Ownership
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
40.00%
BAT
Batero Gold
31.85%
Dios Exploration Inc. stock logo
DOS
Dios Exploration
8.22%
MEX
Mexican Gold Mining
3.44%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
87958.22 million34.93 millionOptionable
BAT
Batero Gold
N/A115.18 millionN/ANot Optionable
Dios Exploration Inc. stock logo
DOS
Dios Exploration
N/A121.28 millionN/ANot Optionable
MEX
Mexican Gold Mining
N/A21.23 millionN/ANot Optionable

ASND, DOS, MKA, BAT, and MEX Headlines

SourceHeadline
Mexican Gold Grants Stock OptionsMexican Gold Grants Stock Options
financialpost.com - November 19 at 8:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Ascendis Pharma A/S logo

Ascendis Pharma A/S

NASDAQ:ASND
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Batero Gold

CVE:BAT
Batero Gold Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in Colombia. The company explores for gold, copper, silver, antimony, hydrargyrum, autonomous system, lead, zinc, and molybdenum deposits. It owns a 100% interest in the Batero-Quinchia project, which consists of 1,407 hectares tenement and one application for a concession contract of 155 hectares located in the municipality of Quinchia, Department of Risaralda, Colombia. The company was formerly known as Angus Resources Inc. and changed its name to Batero Gold Corp. in July 2010. Batero Gold Corp. was incorporated in 2008 and is headquartered in Toronto, Canada.
Dios Exploration logo

Dios Exploration

CVE:DOS
Dios Exploration Inc. engages in the exploration and evaluation of mineral resource properties in Canada. The company explores for lithium, gold, diamond, copper, and silver deposits. Its projects portfolio includes the Le Caron lithium project consisting of 103 mining claims covering an area of 54.14 square kilometers located near the LeCaron Lake; the Nemiscau-North Lithium battery metal property consisting of 164 mining claims covering an area of 927 square kilometers located within Eeyou Istchee James Bay; and the K2 gold project consisting of 68 mining claims covering an area of 35.9 square kilometers situated near the Eastmain River in James Bay. The company also holds interest in the Lithium33 battery metal property consisting of 146 claims covering an area of 7,705 hectares, and the AU33WEST project covering an area of 200 square kilometers, both located near the Eastmain River in James Bay. Dios Exploration Inc. was incorporated in 2000 and is based in Montreal, Canada.

Mexican Gold Mining

CVE:MEX
Mexican Gold Mining Corp., a mineral exploration company, engages in the acquisition, exploration, and evaluation of resource properties in Mexico. The company primarily explores for gold and copper deposits. It holds a 100% interest in the Las Minas project that consists of six mineral concessions located in the Las Minas district in the state of Veracruz, Mexico. Mexican Gold Mining Corp. was incorporated in 2006 and is based in Vancouver, Canada.